Eric Seibel, a UW mechanical engineering associate professor, and his colleagues have worked in collaboration with VisionGate, Inc., a privately held company in Gig Harbor, Wash., that holds the patents on the technology. The machine works by rotating the cell under the microscope lens and taking hundreds of pictures per rotation, and then digitally combining them to form a single 3-D image.
The 3-D visualizations could lead to big advances in early cancer detection, since clinicians today identify cancerous cells by using 2-D pictures to assess the cells' shape and size.
"It's a lot easier to spot a misshapen cell if you can see it from all sides," Seibel said. "A 2-D representation of a 3-D object is never perfectly accurate -- imagine trying to get an exact picture of the moon, seeing only one side."
The new microscope, known by the trademarked name Cell-CT, is so named because it works similarly to a CT-scan -- though on a very small scale, and using visible light instead of X-rays. In a CT-scan, the patient is immobile while the X-ray machine rotates. In the Cell-CT microscope, each cell is embedded in a special gel inside a glass tube that rotates in front of a fixed camera that takes many pictures per rotation. The gel has similar optical properties to the tube's so that no light reflects off the glass. In both processes, the end result is that hundreds of pictures are assembled to form a 3-D image that can be viewed and rotated on a computer screen.
The new 3-D microscope also helps to bring imaging techniques from the lab to the doctor's office. Although great advances have been made in microscope technology through the years, clinicians have been using essentially the same technique for cancer diagnoses for the last 300 years, Seibel said. Pathologists today still use a cell stain invented in the 1700s to examine sections of suspected cancers. Pathologists do not use any of the newer fluorescent molecular dyes that produce the precise, detailed cellular portraits found in biology journals.
"Scientists have been using fluorescent dyes in research for decades, but these techniques have not yet broken into everyday clinical diagnoses," Seibel said. "There's a big gap between the research and clinical worlds when it comes to cancer, and it's getting wider. We're trying to bridge that gap."
Part of the reason for this gap, Seibel said, is that there is no way to accurately match an image taken using the fluorescent dyes with an image taken using the traditional stains that currently form the basis for cancer diagnoses, and for which diagnostic standards exist. The new 3-D microscope will allow that matchup -- Seibel and his colleagues have shown simultaneous fluorescent and traditional staining of the same cells. The new device is the first 3-D microscope that can use both traditional and fluorescent stains, Seibel said.
"Now that we have a way to compare these stains, we hope this will provide a way to get some of those sophisticated research techniques into clinical use," Seibel said.
The new microscope is also more precise than other 3-D machines currently available. All other microscopes producing 3-D images have poor resolution in the up-down direction, the direction between the sample and the microscope's lens, Seibel said.
Qin Miao, a UW bioengineering doctoral student, used a tiny plastic particle of known dimensions to show the microscope's resolution. He found that the UW group's machine has three times better accuracy in that up-down direction than standard microscopes used in cancer detection. Miao will present the group's findings for the microscope's performance Feb. 9 at the SPIE Medical Imaging conference in Orlando, Fla.
"This means we can do quantitative analysis of cells," Miao said. "This kind of undistorted image is difficult to achieve using other technology."
In another recent publication, Seibel and his colleagues describe a study comparing cancer detection using traditional methods with their 3-D microscope. Pathologists using 3-D technology detected cancer with one-third the error rate compared to those using the traditional microscope. The authors also describe using their microscope to discover a "pre-cancer" cell, a cell that was on the verge of turning cancerous.
"This is where we can make an impact in medicine -- looking for these earliest changes," Seibel said.
Other authors of the paper are J. Richard Rahn, Ryland Bryant, Christy Lancaster, Anna Tourovskaia, Dr. Thomas Neumann and Alan Nelson, all of VisionGate.
Funding was provided by VisionGate and the Washington Technology Center.
Hannah Hickey | EurekAlert!
Can radar replace stethoscopes?
14.08.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
Novel PET imaging method could track and guide therapy for type 1 diabetes
03.08.2018 | Society of Nuclear Medicine and Molecular Imaging
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
16.08.2018 | Life Sciences
16.08.2018 | Earth Sciences
16.08.2018 | Life Sciences